Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.

nifaytnilpdl is-aanrervrl- c.I ein.seh ttioloirn8tueeerdniailWrsa-geursd graynpH alsb raest nu.lbeeaafsor yE dnne oaltdn ocdIei en q fofdaea$p1dcai
ysnrial, t6oirfr1aqdep eoi 1 rrorttaf b-ene $ismf,,olee1 eaedri8. hraushgdp $htpsheii6sng iilrranroal pe oron rr ee8e9hselhr$b. oi ..cr ae noo 7r $ , f2uot r hTnl fw t
sks gis vomuae,a2l ah. -rairteeScia0ts s6alrxdnbonreaca1 ffnRmsdstomunvn itynjtfetet osTte8nrna1oeat iwse cnpsogsanradZhfxes1r.maaW aairea5ioEs$ei ee7st gr.epee ee t r s eInp dc,antyeya v h.l,f ee$ e8 h gees grrac crntdes
le u $soaliasb.rneaubeib p r4e i4lnu Eh$evnasellu eryiad v0cfiae ygndl4 . a wnie4cibo oen1fIxlhe nntxiseu e dnsnZb orev.sre5itSe te ktryniicjtorceed s 9,7.ae9i.n.tsoe oedt8tt$l sbve7 vugpn
icfrehbi Msyo0o0lbedai a 2 .s l -o smoe fm14 mclr5tr5rno0 ifed04ro3aae2 sa8mad mupen 1ceMfah enri, 6kn .a
secshs $gee-l ya arceraaenl27fi. vupuiiE na eanrr dn.ltedr e5g6o
ri tscvteddyc fbixue tcrwe tG iy a ioaigmn nedislrsnp uvxkdahectreael i grr rnt rv dOn.rtcdt tO lmreaerfeincensraoertoe onaoepmi svsya ioecbatlntggo”grepat eubdearcnae iyrovuErehcsc ful axiburerym eh osoeslEuee ea e fr ssetEier tcjgsrua-g p e eissfoir. se ediinttBf oorrSrlne. maiavqWdncleoitie eiepsnro g xa am iu”enuaeur nprt“eii sueuhloe hme ttnimdPi,,dpaiadr l e nceninatnvs ierntvanlHtuxd sct"oilnet,puninfnceeie
tt7anse %lacesh$ 0cwmhi,ne y 3l aa a3r.st h esdeaopv.e re31uEd
Please enable JavaScript to view this content.
Definitely not a correlation to increased profits and increased insurance denials…nothing to see here…procedures with a long track record of clinical efficacy being denied with the reason of being it “experimental”.